Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2707170rdf:typepubmed:Citationlld:pubmed
pubmed-article:2707170lifeskim:mentionsumls-concept:C1512505lld:lifeskim
pubmed-article:2707170lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:2707170lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:2707170lifeskim:mentionsumls-concept:C1510932lld:lifeskim
pubmed-article:2707170lifeskim:mentionsumls-concept:C0701303lld:lifeskim
pubmed-article:2707170pubmed:issue5lld:pubmed
pubmed-article:2707170pubmed:dateCreated1989-6-6lld:pubmed
pubmed-article:2707170pubmed:abstractTextOur laboratory has previously reported that physiological levels of progestins stimulate growth of the human breast cancer cell line T47D. We have also determined that the antiprogestin RU486 inhibits this stimulation. Here we present the unexpected finding that RU486 alone also stimulates growth of these breast cancer cells. Thus, RU486 exhibits both antagonist and agonist-like activity, in a manner somewhat reminiscent of the antiestrogen tamoxifen. To our knowledge, this is the first report of stimulation of breast cancer growth by RU486.lld:pubmed
pubmed-article:2707170pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2707170pubmed:languageenglld:pubmed
pubmed-article:2707170pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2707170pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2707170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2707170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2707170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2707170pubmed:statusMEDLINElld:pubmed
pubmed-article:2707170pubmed:monthMaylld:pubmed
pubmed-article:2707170pubmed:issn0013-7227lld:pubmed
pubmed-article:2707170pubmed:authorpubmed-author:MooreM RMRlld:pubmed
pubmed-article:2707170pubmed:authorpubmed-author:HissomJ RJRlld:pubmed
pubmed-article:2707170pubmed:authorpubmed-author:BowdenR TRTlld:pubmed
pubmed-article:2707170pubmed:issnTypePrintlld:pubmed
pubmed-article:2707170pubmed:volume124lld:pubmed
pubmed-article:2707170pubmed:ownerNLMlld:pubmed
pubmed-article:2707170pubmed:authorsCompleteYlld:pubmed
pubmed-article:2707170pubmed:pagination2642-4lld:pubmed
pubmed-article:2707170pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2707170pubmed:meshHeadingpubmed-meshheading:2707170-...lld:pubmed
pubmed-article:2707170pubmed:meshHeadingpubmed-meshheading:2707170-...lld:pubmed
pubmed-article:2707170pubmed:meshHeadingpubmed-meshheading:2707170-...lld:pubmed
pubmed-article:2707170pubmed:meshHeadingpubmed-meshheading:2707170-...lld:pubmed
pubmed-article:2707170pubmed:meshHeadingpubmed-meshheading:2707170-...lld:pubmed
pubmed-article:2707170pubmed:meshHeadingpubmed-meshheading:2707170-...lld:pubmed
pubmed-article:2707170pubmed:meshHeadingpubmed-meshheading:2707170-...lld:pubmed
pubmed-article:2707170pubmed:meshHeadingpubmed-meshheading:2707170-...lld:pubmed
pubmed-article:2707170pubmed:year1989lld:pubmed
pubmed-article:2707170pubmed:articleTitleGrowth stimulation of T47D human breast cancer cells by the anti-progestin RU486.lld:pubmed
pubmed-article:2707170pubmed:affiliationDepartment of Biochemistry, Marshall University School of Medicine, Huntington, West Virginia 25704.lld:pubmed
pubmed-article:2707170pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2707170pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2707170pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2707170lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2707170lld:pubmed